Journal of Ginseng Research

Journal of Ginseng Research (commonly abbreviated as J. Ginseng Res.) is a peer-reviewed journal published by Elsevier on behalf of the Korean Society of Ginseng, with a lineage reaching back to 1976 and now issued bimonthly. It is the only specialist title in ginseng research, publishing the whole chain from cultivation and harvest through constituents, pharmacology and clinic.《人参研究杂志》（Journal of Ginseng Research，常用缩写为 J. Ginseng Res.）是由爱思唯尔代表韩国人参学会出版的同行评审学术期刊，刊脉可溯至 1976 年，现为双月刊。该刊是人参研究领域唯一的专业刊物，刊载从栽培与采收到成分、药理与临床的完整研究链条。

Scope

Journal of Ginseng Research treats ginseng as a discipline amenable to quantification, requiring papers to discuss saponin constituents, mechanism of action and physiological effect together rather than reporting the efficacy of crude extracts alone. Its principal subject areas include:Journal of Ginseng Research 的取稿立场是「把人参当作一门可量化的学科来研究」，要求论文把皂苷成分、作用机制与生理效应放在一起讨论，而非只报告粗提物的功效。收文范围覆盖的主要方向包括：

• Constituents and chemistry: isolation and structural identification of ginsenosides, conversion of rare ginsenosides, and the relation between content and provenance or processing.成分与化学： 人参皂苷的分离与结构鉴定、稀有人参皂苷的转化、成分含量与产地加工的关系。
• Cultivation and breeding: cultivation technique and replant failure, variety breeding with germplasm, and the effect of harvest time and processing.栽培与育种： 人参栽培技术与连作障碍、品种选育与种质资源、采收期与加工方式的影响。
• Pharmacology and mechanism: immunomodulation and anti-fatigue action, metabolic and cardiovascular protection, and neuroprotection with cognitive function.药理与机制： 免疫调节与抗疲劳作用、代谢与心血管保护、神经保护与认知功能研究。
• Clinical and safety: human trials and randomised studies, dose and course exploration, and drug interactions with adverse effects.临床与安全性： 人体试验与随机对照研究、剂量与疗程探索、药物相互作用与不良反应。
• Analysis and quality control: fingerprinting and assay, authentication of provenance and detection of adulteration, and standardised extracts with specifications.分析与质量控制： 指纹图谱与含量测定、掺伪与产地鉴别、标准提取物与质量规范。

Research articles and reviews predominate, with short communications accepted, and ginseng material must be identified by species, provenance and growth years, since omission is caught at technical check.稿件类型以研究论文与综述为主，兼收短篇通讯；本刊要求人参材料标明物种、产地与年限，缺少这些信息的稿件在技术审查阶段即被退回。

History

• Founding (1976): the line reaches back to the Koryo Insam Hakhoe chi published in Korean from 1976, when ginseng research in Korea was widening from agriculture into pharmacology.创刊（1976年）： 本刊的谱系上溯至 1976 年以韩文出版的《高丽人参学会志》，其时韩国人参研究正从农学扩展至药理学。
• Renaming and internationalisation (1998): the present name was adopted from volume 22 in March 1998 together with a switch to English publication, numbering continuing from the predecessor and the journal entering international indexing.改名与国际化（1998年）： 1998 年 3 月本刊自第 22 卷起改用现名并转为以英文发表，卷号承接前身，从此进入国际检索体系。
• Publisher history: publication was long handled by the society itself before Elsevier took over production and distribution, with editorial authority retained by the society and Korea as the place of record.出版方沿革： 本刊长期由学会自行出版，其后改由爱思唯尔承担生产与发行，编辑权仍属学会，注册地为韩国。
• Metric trend: the impact factor rose from 4.1 in 2017 to 5.7 in 2021 and reached 7.5 in 2025, upper-ranked in medicinal chemistry and in integrative and complementary medicine.指标走势： 影响因子自 2017 年的 4.1 上升至 2021 年的 5.7，2025 年达 7.5，在药物化学与补充医学两个类目中均列上游。

Editors

An editor-in-chief directs the journal with an international board drawn mainly from Korean pharmaceutical and agricultural institutions but including overseas ginseng researchers. Manuscripts arrive online, and refereeing stresses identification of constituents and statement of dose. Neither the publisher nor the board publishes an acceptance rate or review duration for the title.本刊由主编统筹并设国际编委会，成员以韩国药学与农学研究机构为主，亦含海外人参研究者；稿件经在线系统投递，评审强调成分的指认与剂量的交代。出版方与编委会均未公布本刊的录用比例与审稿时长。

• Species and plant part: materials must be specified as ginseng, American ginseng or notoginseng, with the plant part stated, and vague or mixed descriptions are sent back for clarification.物种与部位： 编辑部要求明确所用材料是人参、西洋参还是三七，并写明用药部位，混用或含糊的表述会被要求澄清。
• Extract standardisation: assays of saponin constituents and reference standards must be given in full, and papers summarised only as total saponin content are often asked for more.提取物标准化： 皂苷类成分的含量测定与对照品信息须完整给出，仅以总皂苷含量概括的稿件常被要求补作。
• Society and meetings: the journal exists as the society's title, and papers from its scientific meetings are frequently gathered into topical issues.学会与会议： 本刊作为韩国人参学会的会刊存在，学会学术会议的专题稿件常就地结集刊发。